NORD Issues Statement in Response to PDUFA VI Commitment Letter
Written by Rose Gallagher on July 21, 2016
On July 15, the Food and Drug Administration released the performance goals letter for the reauthorization of the Prescription Drug User Fee Act, also known as PDUFA VI. The PDUFA program is the agreement between the FDA and the pharmaceutical industry to pay user fees to facilitate the… Read More
